Tower Research Capital (TRC)’s Baird Medical Investment Holdings BDMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-241
Closed -$883 5723
2025
Q2
$883 Buy
+241
New +$1.26K ﹤0.01% 4920
2025
Q1
Sell
-297
Closed -$2.26K 5947
2024
Q4
$2.26K Buy
+297
New +$820 ﹤0.01% 4879

Other funds holding BDMD

Tower Research Capital (TRC)'s BDMD Position: Q3 2025 in Review

Tower Research Capital (TRC) sold out of Baird Medical Investment Holdings (BDMD) in Q3 2025, closing a stake of 241 shares — an estimated $883 sold.

Tower Research Capital (TRC) first reported a position in BDMD in Q4 2024 and held it in 2 quarters. The position peaked at $2.26K in Q4 2024. 8 funds tracked by Wall St. Rank hold BDMD as of Q3 2025.

  • Tower Research Capital (TRC) reported no remaining Baird Medical Investment Holdings position as of Q3 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 241 Baird Medical Investment Holdings shares in Q3 2025, an estimated $883.
  • Tower Research Capital (TRC) first reported a position in Baird Medical Investment Holdings in Q4 2024 and held it in 2 quarters.
  • Tower Research Capital (TRC)'s Baird Medical Investment Holdings position peaked at $2.26K in Q4 2024.
  • 8 funds tracked by Wall St. Rank held Baird Medical Investment Holdings as of Q3 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2025, filed 14 Nov 2025.